000617347 001__ 617347
000617347 005__ 20250723172706.0
000617347 0247_ $$2doi$$a10.1016/j.ijbiomac.2024.131268
000617347 0247_ $$2ISSN$$a0141-8130
000617347 0247_ $$2ISSN$$a1879-0003
000617347 0247_ $$2pmid$$a38580011
000617347 0247_ $$2WOS$$aWOS:001285901200001
000617347 0247_ $$2openalex$$aopenalex:W4393948455
000617347 037__ $$aPUBDB-2024-06713
000617347 041__ $$aEnglish
000617347 082__ $$a570
000617347 1001_ $$0P:(DE-H253)PIP1032135$$aRasheed, Saima$$b0$$eCorresponding author
000617347 245__ $$aIdentification, crystallization, and first X-ray structure analyses of phenyl boronic acid-based inhibitors of human carbonic anhydrase-II
000617347 260__ $$aNew York, NY [u.a.]$$bElsevier$$c2024
000617347 3367_ $$2DRIVER$$aarticle
000617347 3367_ $$2DataCite$$aOutput Types/Journal article
000617347 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1738076598_2493351
000617347 3367_ $$2BibTeX$$aARTICLE
000617347 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000617347 3367_ $$00$$2EndNote$$aJournal Article
000617347 500__ $$aWaiting for fulltext 
000617347 520__ $$aHuman carbonic anhydrases (hCAs) play a central role in various physiological processes in the human body. HCAs catalyze the reversible hydration of CO2 into HCO3−, and hence maintains the fluid and pH balance. Overexpression of CA II is associated with diseases, such as glaucoma, and epilepsy. Therefore, CAs are important clinical targets and inhibition of different isoforms, especially hCA II is used in treatment of glaucoma, altitude sickness, and epilepsy. Therapeutically used CA inhibitors (CAI) are sulfonamide-based, such as acetazolamide, dichlorphenamide, methazolamide, ethoxzolamide, etc. However, they exhibit several undesirable effects such as numbness, tingling of extremities, malaise, metallic taste, fatigue, renal calculi, and metabolic acidosis. Therefore, there is an urgent need to identify safe and effective inhibitors of the hCAs. In this study, different phenyl boronic acids 1–5 were evaluated against bovine (bCA II) and hCA II. Among all, compound 1 (4-acetylphenyl boronic acid) was found to be active against bCAII and hCA II with IC50 values of 246 ± 0.48 and 281.40 ± 2.8 μM, respectively, while the remaining compounds were found in-active. Compound 1 was identified as competitive inhibitor of hCA II enzyme (Ki = 283.7 ± 0.002 μM). Additionally, compound 1 was found to be non-toxic against BJ Human fibroblast cell line. The X-ray crystal structure for hCA II in-complex with compound 1 was evaluated to a resolution of 2.6 Å. In fact, this the first structural analysis of a phenyl boron-based inhibitor bound to hCA II, allowing an additional structure-activity analysis of the compounds. Compound 1 was found to be directly bound in the active site of hCA II by interacting with His94, His119, and Thr199 residues. In addition, a bond of 3.11 Å between the zinc ion and coordinated boron atom of the boronic acid moiety of compound 1 was also observed, contributing to binding affinity of compound 1 for hCA II.
000617347 536__ $$0G:(DE-HGF)POF4-633$$a633 - Life Sciences – Building Blocks of Life: Structure and Function (POF4-633)$$cPOF4-633$$fPOF IV$$x0
000617347 542__ $$2Crossref$$i2024-05-01$$uhttps://www.elsevier.com/tdm/userlicense/1.0/
000617347 542__ $$2Crossref$$i2024-05-01$$uhttps://www.elsevier.com/legal/tdmrep-license
000617347 542__ $$2Crossref$$i2024-05-01$$uhttps://doi.org/10.15223/policy-017
000617347 542__ $$2Crossref$$i2024-05-01$$uhttps://doi.org/10.15223/policy-037
000617347 542__ $$2Crossref$$i2024-05-01$$uhttps://doi.org/10.15223/policy-012
000617347 542__ $$2Crossref$$i2024-05-01$$uhttps://doi.org/10.15223/policy-029
000617347 542__ $$2Crossref$$i2024-05-01$$uhttps://doi.org/10.15223/policy-004
000617347 588__ $$aDataset connected to CrossRef, Journals: bib-pubdb1.desy.de
000617347 693__ $$0EXP:(DE-MLZ)External-20140101$$5EXP:(DE-MLZ)External-20140101$$eMeasurement at external facility$$x0
000617347 7001_ $$0P:(DE-HGF)0$$aHuda, Noor ul$$b1
000617347 7001_ $$0P:(DE-HGF)0$$aFisher, S. Zoë$$b2
000617347 7001_ $$0P:(DE-H253)PIP1089186$$aFalke, Sven$$b3
000617347 7001_ $$0P:(DE-HGF)0$$aGul, Sadaf$$b4
000617347 7001_ $$0P:(DE-H253)PIP1032133$$aAhmad, Malik Shoaib$$b5
000617347 7001_ $$0P:(DE-H253)PIP1092561$$aChoudhary, M. Iqbal$$b6
000617347 77318 $$2Crossref$$3journal-article$$a10.1016/j.ijbiomac.2024.131268$$bElsevier BV$$d2024-05-01$$p131268$$tInternational Journal of Biological Macromolecules$$v267$$x0141-8130$$y2024
000617347 773__ $$0PERI:(DE-600)1483284-7$$a10.1016/j.ijbiomac.2024.131268$$gVol. 267, p. 131268 -$$p131268$$tInternational journal of biological macromolecules$$v267$$x0141-8130$$y2024
000617347 8564_ $$uhttps://www.sciencedirect.com/science/article/pii/S0141813024020737?via%3Dihub
000617347 8564_ $$uhttps://bib-pubdb1.desy.de/record/617347/files/1-s2.0-S0141813024020737-main.pdf$$yRestricted
000617347 8564_ $$uhttps://bib-pubdb1.desy.de/record/617347/files/1-s2.0-S0141813024020737-main.pdf?subformat=pdfa$$xpdfa$$yRestricted
000617347 909CO $$ooai:bib-pubdb1.desy.de:617347$$pVDB
000617347 9101_ $$0I:(DE-HGF)0$$6P:(DE-H253)PIP1032135$$aExternal Institute$$b0$$kExtern
000617347 9101_ $$0I:(DE-588b)2008985-5$$6P:(DE-H253)PIP1089186$$aDeutsches Elektronen-Synchrotron$$b3$$kDESY
000617347 9101_ $$0I:(DE-H253)_CFEL-20120731$$6P:(DE-H253)PIP1089186$$aCentre for Free-Electron Laser Science$$b3$$kCFEL
000617347 9101_ $$0I:(DE-588b)235011-7$$6P:(DE-H253)PIP1089186$$aEuropean Molecular Biology Laboratory$$b3$$kEMBL
000617347 9101_ $$0I:(DE-HGF)0$$6P:(DE-H253)PIP1089186$$aExternal Institute$$b3$$kExtern
000617347 9101_ $$0I:(DE-HGF)0$$6P:(DE-H253)PIP1032133$$aExternal Institute$$b5$$kExtern
000617347 9101_ $$0I:(DE-HGF)0$$6P:(DE-H253)PIP1092561$$aExternal Institute$$b6$$kExtern
000617347 9131_ $$0G:(DE-HGF)POF4-633$$1G:(DE-HGF)POF4-630$$2G:(DE-HGF)POF4-600$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bForschungsbereich Materie$$lVon Materie zu Materialien und Leben$$vLife Sciences – Building Blocks of Life: Structure and Function$$x0
000617347 9141_ $$y2024
000617347 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-10-21
000617347 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2023-10-21
000617347 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-10-21
000617347 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2024-12-21$$wger
000617347 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-21
000617347 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-21
000617347 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-21
000617347 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-21
000617347 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-21
000617347 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-21
000617347 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-21
000617347 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-21
000617347 9201_ $$0I:(DE-H253)FS-CFEL-1-BMX-20210408$$kFS-CFEL-1-BMX$$lFS-CFEL-1 Fachgruppe BMX$$x0
000617347 980__ $$ajournal
000617347 980__ $$aVDB
000617347 980__ $$aI:(DE-H253)FS-CFEL-1-BMX-20210408
000617347 980__ $$aUNRESTRICTED
000617347 999C5 $$1Supuran$$2Crossref$$9-- missing cx lookup --$$a10.1080/17460441.2020.1743676$$p671 -$$tExpert Opin. Drug Discovery$$v15$$y2020
000617347 999C5 $$1Itada$$2Crossref$$9-- missing cx lookup --$$a10.1016/S0021-9258(17)40334-6$$p3881 -$$tJ. Biol. Chem.$$v252$$y1977
000617347 999C5 $$1Türkeş$$2Crossref$$9-- missing cx lookup --$$a10.1002/jmr.3063$$tJ. Mol. Recognit.$$v36$$y2023
000617347 999C5 $$1Mishra$$2Crossref$$9-- missing cx lookup --$$a10.1002/med.21713$$p2485 -$$tMed. Res. Rev.$$v40$$y2020
000617347 999C5 $$1Itada$$2Crossref$$9-- missing cx lookup --$$a10.1016/S0021-9258(17)40334-6$$p3881 -$$tJ. Biol. Chem.$$v252$$y1977
000617347 999C5 $$1Mishra$$2Crossref$$9-- missing cx lookup --$$a10.1002/med.21713$$p2485 -$$tMed. Res. Rev.$$v40$$y2020
000617347 999C5 $$1Osmaniye$$2Crossref$$9-- missing cx lookup --$$a10.1002/ardp.202200132$$tArch. Pharm.$$v355$$y2022
000617347 999C5 $$1Supuran$$2Crossref$$9-- missing cx lookup --$$a10.3109/14756366.2015.1122001$$p345 -$$tJ. Enzyme Inhib. Med. Chem.$$v31$$y2016
000617347 999C5 $$1Winum$$2Crossref$$9-- missing cx lookup --$$a10.3109/14756366.2014.913587$$p321 -$$tJ. Enzyme Inhib. Med. Chem.$$v30$$y2015
000617347 999C5 $$1Tars$$2Crossref$$9-- missing cx lookup --$$a10.1021/jm301625s$$p293 -$$tJ. Med. Chem.$$v56$$y2013
000617347 999C5 $$1Ferraroni$$2Crossref$$9-- missing cx lookup --$$a10.1021/acs.jmedchem.5b01720$$p462 -$$tJ. Med. Chem.$$v59$$y2016
000617347 999C5 $$1Sechi$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.bmcl.2012.07.094$$p5801 -$$tBioorg. Med. Chem. Lett.$$v22$$y2012
000617347 999C5 $$1Vullo$$2Crossref$$9-- missing cx lookup --$$a10.1021/acs.jmedchem.6b00462$$p5857 -$$tJ. Med. Chem.$$v59$$y2016
000617347 999C5 $$1Carta$$2Crossref$$9-- missing cx lookup --$$a10.1039/c2cc16395k$$p1868 -$$tChemical Communications$$v48$$y2012
000617347 999C5 $$1Di Fiore$$2Crossref$$9-- missing cx lookup --$$a10.1039/c2cc34275h$$p8838 -$$tChem. Commun.$$v48$$y2012
000617347 999C5 $$1Istrefi$$2Crossref$$9-- missing cx lookup --$$a10.1002/ardp.201900383$$tArch. Pharm.$$v353$$y2020
000617347 999C5 $$1Türkeş$$2Crossref$$oTürkeş 2022$$y2022
000617347 999C5 $$1Supuran$$2Crossref$$9-- missing cx lookup --$$a10.1080/17460441.2020.1743676$$p671 -$$tExpert Opin. Drug Discovery$$v15$$y2020
000617347 999C5 $$1Fernandes$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.ejmech.2019.06.092$$p791 -$$tEur. J. Med. Chem.$$v179$$y2019
000617347 999C5 $$1Yang$$2Crossref$$9-- missing cx lookup --$$a10.1002/med.10043$$p346 -$$tMed. Res. Rev.$$v23$$y2003
000617347 999C5 $$1Baker$$2Crossref$$9-- missing cx lookup --$$a10.4155/fmc.09.71$$p1275 -$$tFuture Med. Chem.$$v1$$y2009
000617347 999C5 $$1Groziak$$2Crossref$$9-- missing cx lookup --$$a10.1097/00045391-200109000-00005$$p321 -$$tAm. J. Ther.$$v8$$y2001
000617347 999C5 $$1Yusuf$$2Crossref$$9-- missing cx lookup --$$a10.1080/14756366.2022.2072837$$p1340 -$$tJ. Enzyme Inhib. Med. Chem.$$v37$$y2022
000617347 999C5 $$1Winum$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.bmc.2009.03.058$$p3649 -$$tBioorg. Med. Chem.$$v17$$y2009
000617347 999C5 $$1Innocenti$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.bmcl.2009.03.147$$p2642 -$$tBioorg. Med. Chem. Lett.$$v19$$y2009
000617347 999C5 $$1DiáFiore$$2Crossref$$9-- missing cx lookup --$$a10.1039/C6CC06399C$$p11983 -$$tChem. Commun.$$v52$$y2016
000617347 999C5 $$1Larcher$$2Crossref$$9-- missing cx lookup --$$a10.1021/acsmedchemlett.9b00252$$p1205 -$$tACS Med. Chem. Lett.$$v10$$y2019
000617347 999C5 $$1Aggarwal$$2Crossref$$9-- missing cx lookup --$$a10.1107/S2052252516010514$$p319 -$$tIUCrJ$$v3$$y2016
000617347 999C5 $$1Shank$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.eplepsyres.2005.01.001$$p103 -$$tEpilepsy Res.$$v63$$y2005
000617347 999C5 $$1Fisher$$2Crossref$$9-- missing cx lookup --$$a10.1107/S1744309106020446$$p618 -$$tActa Crystallogr. Sect. F Struct. Biol. Cryst. Commun.$$v62$$y2006
000617347 999C5 $$1Evans$$2Crossref$$9-- missing cx lookup --$$a10.1107/S090744491003982X$$p282 -$$tActa Crystallogr. D Biol. Crystallogr.$$v67$$y2011
000617347 999C5 $$1Vagin$$2Crossref$$9-- missing cx lookup --$$a10.1107/S0907444909042589$$p22 -$$tActa Crystallogr. D Biol. Crystallogr.$$v66$$y2010
000617347 999C5 $$1Potterton$$2Crossref$$9-- missing cx lookup --$$a10.1107/S2059798317016035$$p68 -$$tActa Crystallographica Section D: Structural Biology$$v74$$y2018
000617347 999C5 $$1Murshudov$$2Crossref$$9-- missing cx lookup --$$a10.1107/S0907444911001314$$p355 -$$tActa Crystallogr. D Biol. Crystallogr.$$v67$$y2011
000617347 999C5 $$1Emsley$$2Crossref$$9-- missing cx lookup --$$a10.1107/S0907444904019158$$p2126 -$$tActa Crystallogr. D Biol. Crystallogr.$$v60$$y2004
000617347 999C5 $$1Askin$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.bioorg.2021.105009$$tBioorg. Chem.$$v113$$y2021
000617347 999C5 $$1Mannerström$$2Crossref$$9-- missing cx lookup --$$a10.1111/bcpt.12790$$p109 -$$tBasic Clin. Pharmacol. Toxicol.$$v121$$y2017
000617347 999C5 $$1Price$$2Crossref$$oPrice 1990$$y1990
000617347 999C5 $$1Buza$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.ijbiomac.2023.124232$$tInt. J. Biol. Macromol.$$v239$$y2023
000617347 999C5 $$1Kakakhan$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.bmc.2022.117111$$tBioorg. Med. Chem.$$v77$$y2023
000617347 999C5 $$1Joosten$$2Crossref$$9-- missing cx lookup --$$a10.1107/S2052252514009324$$p213 -$$tIUCrJ$$v1$$y2014
000617347 999C5 $$1Schrödinger$$2Crossref$$oSchrödinger 2020$$y2020